Singapore markets closed
Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
66,260.25 +120.51 (+0.18%) CMC Crypto 200
1,376.31 -41.56 (-2.93%)
Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 51.83B |
| Enterprise value | 50.34B |
| Trailing P/E | 18.71 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.27 |
| Price/book (mrq) | 2.33 |
| Enterprise value/revenue | 2.28 |
| Enterprise value/EBITDA | 11.51 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.07 |
| 52-week change 3 | 7.87% |
| S&P500 52-week change 3 | 23.76% |
| 52-week high 3 | 35.49 |
| 52-week low 3 | 21.60 |
| 50-day moving average 3 | 32.06 |
| 200-day moving average 3 | 28.74 |
Share statistics
| Avg vol (3-month) 3 | 15.66M |
| Avg vol (10-day) 3 | 16.78M |
| Shares outstanding 5 | 1.6B |
| Implied shares outstanding 6 | 1.6B |
| Float 8 | 1.01B |
| % held by insiders 1 | 32.89% |
| % held by institutions 1 | 20.45% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.8 |
| Forward annual dividend yield 4 | 2.47% |
| Trailing annual dividend rate 3 | 0.80 |
| Trailing annual dividend yield 3 | 2.49% |
| 5-year average dividend yield 4 | 1.75 |
| Payout ratio 4 | 35.61% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 29 May 2024 |
| Last split factor 2 | 20:10 |
| Last split date 3 | 22 Jul 2015 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 12.11% |
| Operating margin (ttm) | 23.91% |
Management effectiveness
| Return on assets (ttm) | 6.35% |
| Return on equity (ttm) | 13.37% |
Income statement
| Revenue (ttm) | 22.04B |
| Revenue per share (ttm) | 14.90 |
| Quarterly revenue growth (yoy) | 10.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 4.93B |
| Net income avi to common (ttm) | 2.67B |
| Diluted EPS (ttm) | 1.73 |
| Quarterly earnings growth (yoy) | 26.00% |
Balance sheet
| Total cash (mrq) | 6.83B |
| Total cash per share (mrq) | 4.46 |
| Total debt (mrq) | 5.35B |
| Total debt/equity (mrq) | 20.67% |
| Current ratio (mrq) | 1.98 |
| Book value per share (mrq) | 14.53 |
Cash flow statement
| Operating cash flow (ttm) | 5.11B |
| Levered free cash flow (ttm) | -324.26M |
© 2024 Yahoo. All rights reserved.